Newcore Capital has reached a second close for its £375m core-plus income fund, NSIIF, a fund that seeks high-quality, income-producing social infrastructure real estate with a target net return of 9–11% pa. The second close takes total commitments to over £100m (US$136m). The investment strategy seeks to improve local supply and...
Epidarex Capital, a UK-based transatlantic life science venture firm, has announced the first close of Epidarex Capital Fund IV, securing more than US$145m in commitments to build therapeutics and medical device companies in the UK and the US.
“This first close reflects strong conviction in Epidarex’s ability to build high-quality life science companies from the earliest stages,” said Elizabeth Roper, managing partner at Epidarex. “We work closely with founders to support them through critical development milestones. Fund IV allows us to continue executing on this strategy.”
The Fund’s initial investors include...
